ELLANSÉ-S

polycaprolactone dermal filler (PCL-based) · AQTIS Medical B.V.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for ELLANSÉ-S, covering 2025-04-29 to 2025-05-22. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Effectiveness of ELLANSÉ®-S Dermal Filler in the Treatment of Nasolabial Folds [NA]